A
Aneira Pharma
We are creating the future of hair growth
About Aneira Pharma
Aneira Pharma is pioneering the future of hair growth with its innovative formulation designed to significantly grow, thicken, and darken hair for most men and women. Operating in the healthcare and beauty market, Aneira Pharma targets individuals experiencing hair loss or thinning hair. The company employs a direct-to-consumer business model, selling its products through its website and other online platforms. Revenue is generated through product sales, leveraging cutting-edge science and technology to differentiate from traditional hair loss solutions. Aneira has successfully raised $25 million in funding and is set to begin phase I/IIa clinical trials in the first half of 2021. The leadership team comprises experienced professionals with a proven track record in the industry, aiming to launch products that will eventually benefit millions of people.
Source: Dealroom company dataAt a glance
- Founded
- 2021
- Headquarters
- San Diego, United States
- Sector
- Wellness Beauty
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Valkyrie Group
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Aneira Pharma on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Aneira Pharma on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.